ICU Medical, Inc. (ICUI) financial statements and ratios from SEC XBRL: revenue $2.23B (TTM), net margin 0.0%, revenue growth -6.3% YoY, P/E 97.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.23B |
| Net Margin | 0.0% |
| Revenue Growth (YoY) | -6.3% |
| EPS Growth (YoY) | -100.6% |
| FCF Growth (YoY) | -26.4% |
| P/E Ratio | 97.8 |
| EV / EBITDA | 30.0 |
| Price / Book | 2.16 |
| Price / Sales | 2.05 |
| FCF Yield | 3.3% |
| DCF Value (model) | $83.68 |
| DCF Upside vs Price | -54.1% |
| Altman Z-Score | 2.43 (grey) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
ICUI overview · ICUI earnings · ICUI KPIs · ICUI investor relations · ICUI ownership · ICUI peers · ICUI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.